0.7500
-0.0152
(-1.99%)
收市：January 31 at 4:00:01 PM EST
0.7400
-0.01
(-1.33%)
收市後：January 31 at 6:46:09 PM EST
內部人士陣容
內幕名冊數據僅來自最近 24 個月美國證券交易委員會 (SEC) 申報文件表格 3 及表格 4。
| 個人或機構 | 最近一次交易 | 日期 | 成交日期截止前持股股數 |
|---|---|---|---|
| ABILDGAARD OLE Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 13, 2024 | -- |
| GRONFELDT-SORENSEN HENRIK Director | Purchase | Jan 10, 2019 | -- |
| GUMRUKCU SERHAT Beneficial Owner of more than 10% of a Class of Security | Sale | May 18, 2022 | 16,985,800 |
| LEIRE ERIC JEAN MARIE Chief Executive Officer | Purchase | May 24, 2018 | 73,246 |
| MILLER AVRAM Director | Stock Award(Grant) | Oct 23, 2023 | 1,000,000 |
| PUCHE LUISA Chief Financial Officer | Stock Award(Grant) | Dec 16, 2021 | 16,266 |
| SANDLER CARL FOREST JR Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 22, 2022 | 8,418,190 |
| SINDLEV RENE Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 20, 2024 | -- |
| WEINSTEIN DAVID HERSHEL Chief Executive Officer | Stock Award(Grant) | Oct 14, 2024 | 250,000 |
| WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 29, 2024 | -- |
相關股票代號
PEG.CO Pharma Equity Group A/S
0.1590
+1.27%
CNSP CNS Pharmaceuticals, Inc.
0.0951
-4.71%
TPST Tempest Therapeutics, Inc.
0.9150
-3.17%
NBY NovaBay Pharmaceuticals, Inc.
0.6655
+2.38%
LYEL Lyell Immunopharma, Inc.
0.5903
+1.22%
NKGN NKGen Biotech, Inc.
0.4885
+0.33%
ATNF 180 Life Sciences Corp.
1.4000
-2.78%
IBO Impact BioMedical Inc.
1.7499
-5.62%
CGTX Cognition Therapeutics, Inc.
0.7230
-5.90%
COEP Coeptis Therapeutics Holdings, Inc.
12.95
+1.09%